The National Academy of Sciences and the National Academy of Medicine launched this initiative to inform decision-making related to recent advances in human gene-editing research. [Learn about related Academies’ studies and reports on genetic research]
Now Available: Archived February Webinar About Developments and Advancements in Human Genome Editing
With the recent scientific advances making genome editing more efficient, precise, and flexible than ever before came an explosion of interest from around the globe in the possible ways human genome editing can improve human health. As part of the Human Gene-Editing Initiative, the National Academy of Sciences and National Academy of Medicine released a consensus study report last year exploring the scientific underpinnings of human gene-editing technologies, their potential applications in biomedical research and medicine, and the clinical, ethical, legal, and social implications of their use.
On Thursday, Feb. 22, 2018, NAS/NAM and the Biotechnology Innovation Organization (BIO) co-hosted a webinar to learn about issues and recommendations discussed in the 2017 NAS/NAM report, breakthroughs and next steps in gene editing of somatic cells, and the regulatory framework for therapies that make use of genome editing.
Participants in the webinar included:
Matthew Porteus, Stanford University (consensus study committee member)
Sandy Macrae, Sangamo Therapeutics
Peter Marks, U.S. Food and Drug Administration